Future therapies for food allergy

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 10, 2012, Pages 1479-1484

  McWilliams, Laurie M ^a   Mousallem, Talal ^a   Burks, A Wesley ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylaxis; Desensitization; Food allergy; Oral immunotherapy; Subcutaneous immunotherapy; Sublingual immunotherapy; Tolerance

Indexed keywords

EID: 84868267215     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20868     Document Type: Review

References (48)

1. Branum AM, Lukacs SL. Food allergy among US children: trends in prevalence and hospitalizations. NCHS Data Brief 2008; 10:1-8; PMID:19389315.
2. Ker J, Hartert TV. The atopic march: what's the evidence? Ann Allergy Asthma Immunol 2009; 103:282- 9; PMID:19852191; http://dx.doi.org/10.1016/ S1081-1206(10)60526-1.
3. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2007; 62:91-6; PMID:16950836; http://dx.doi.org/10. 1136/ thx.2004.038844.
4. Lee LA, Burks AW. Food allergies: prevalence, molecular characterization and treatment/prevention strategies. Annu Rev Nutr 2006; 26:539-65; PMID:16602930; http://dx.doi.org/10.1146/annurev. nutr.26.061505.111211.
5. Weiner HL. Oral tolerance. Proc Natl Acad Sci USA 1994; 91:10762-5; PMID:7971958; http://dx.doi. org/10.1073/pnas.91.23.10762.
6. Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008; 121:1344- 50; PMID:18410959; http://dx.doi.org/10.1016/j. jaci.2008.02.037.
7. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005; 115:3-12; PMID:15637539; http://dx.doi. org/10.1016/j.jaci.2004.11.008.
8. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics 2009; 124:1549- 55; PMID:19917585; http://dx.doi.org/10.1542/ peds.2009-1210.
9. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191-3; PMID:11150011; http:// dx.doi.org/10.1067/mai.2001.112031.
10. Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food2001- 2006. J Allergy Clin Immunol 2007; 119:1016-8; PMID:17306354; http://dx.doi.org/10.1016/j. jaci.2006.12.622.
11. Krishna MT, Huissoon AP. Clinical immunology review series: an approach to desensitization. Clin Exp Immunol 2011; 163:131-46; PMID:21175592; http:// dx.doi.org/10.1111/j.1365-2249.2010.04296.x.
12. Golden DB, Valentine MD, Kagey-Sobotka A, Lichtenstein LM. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med 1980; 92:620-4; PMID:7387002.
13. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299:157-61; PMID:78446; http://dx.doi. org/10.1056/NEJM197807272990401.
14. Freeman J. Rush innoculation, with a special reference to hay fever treatment. Lancet 1930; 1:744-7; http:// dx.doi.org/10.1016/S0140-6736(00)88249- 5.
15. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90:256- 62; PMID:1500630; http://dx.doi.org/10.1016/0091- 6749(92)90080-L.
16. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99:744-51; PMID:9215240; http://dx.doi.org/10.1016/S0091- 6749(97)80006-1.
17. Schofield A. A case of egg poisoning. Lancet 1908; 171:716; http://dx.doi.org/10.1016/S0140- 6736(00)67313-0.
18. Patriarca G, Schiavino D, Nucera E, Schinco G, Milani A, Gasbarrini GB. Food allergy in children: results of a standardized protocol for oral desensitization. Hepatogastroenterology 1998; 45:52-8; PMID:9496487.
19. Patriarca C, Romano A, Venuti A, Schiavino D, Di Rienzo V, Nucera E, et al. Oral specific hyposensitization in the management of patients allergic to food. Allergol Immunopathol (Madr) 1984; 12:275-81; PMID:6507224.
20. Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008; 122:1154-60; PMID:18951617; http://dx.doi. org/10.1016/j.jaci.2008.09.030.
21. Wachholz PA, Durham SR. Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol 2004; 4:313-8; PMID:15238798; http:// dx.doi.org/10.1097/01.all.0000136753.35948.c0.
22. Uermösi C, Beerli RR, Bauer M, Manolova V, Dietmeier K, Buser RB, et al. Mechanisms of allergen- specific desensitization. J Allergy Clin Immunol 2010; 126:375-83; PMID:20624641; http://dx.doi. org/10.1016/j.jaci.2010.05.040.
23. Brozek JL, Terracciano L, Hsu J, Kreis J, Compalati E, Santesso N, et al. Oral immunotherapy for IgEmediated cow's milk allergy: a systematic review and meta-analysis. Clin Exp Allergy 2012; 42:363-74; PMID:22356141; http://dx.doi.org/10.1111/j.1365- 2222.2011.03948.x.
24. Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie L, Althage KA, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007; 119:199-205; PMID:17208602; http://dx.doi.org/10. 1016/j.jaci.2006.09.016.
25. Vickery BP, Pons L, Kulis M, Steele P, Jones SM, Burks AW. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 2010; 105:444- 50; PMID:21130382; http://dx.doi.org/10.1016/j. anai.2010.09.030.
26. Jones SM. A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Egg Oral Immunotherapy in Children: An Analysis of Clinical Tolerance. J Allergy Clin Immunol 2012; 129:65; http://dx.doi.org/10.1016/j.jaci.2011.12. 736.
27. Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 127:654-60; PMID:21377034; http:// dx.doi.org/10.1016/j.jaci.2010.12.1111.
28. Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009; 124:286- 91; PMID:19477496; http://dx.doi.org/10.1016/j. jaci.2009.03.045.
29. Varshney P, Steele PH, Vickery BP, Bird JA, Thyagarajan A, Scurlock AM, et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009; 124:1351-2; PMID:19913285; http:// dx.doi.org/10.1016/j. jaci.2009.09.042.
30. Enrique E, Pineda F, Malek T, Bartra J, Basagaña M, Tella R, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116:1073- 9; PMID:16275379; http://dx.doi.org/10.1016/j. jaci.2005.08.027.
31. Kim EH, Bird JA, Kulis M, Laubach S, Pons L, Shreffler W, et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 2011; 127:640-6; PMID:21281959; http://dx.doi. org/10.1016/j.jaci.2010.12.1083.
32. Fernández-Rivas M, Garrido Fernández S, Nadal JA, Díaz de Durana MD, García BE, González-Mancebo E, et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009; 64:876-83; PMID:19183164; http://dx.doi.org/10.1111/j.1398- 9995.2008.01921.x.
33. Kelso JM, Jones RT, Tellez R, Yunginger JW. Oral allergy syndrome successfully treated with pollen immunotherapy. Ann Allergy Asthma Immunol 1995; 74:391-6; PMID:7749969.
34. Bolhaar ST, Tiemessen MM, Zuidmeer L, van Leeuwen A, Hoffmann- Sommergruber K, Bruijnzeel-Koomen CA, et al. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 2004; 34:761-9; PMID:15144469; http://dx.doi. org/10.1111/j.1365-2222.2004.1939.x.
35. Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 1998; 28:1368-73; PMID:9824409; http://dx.doi.org/10.1046/j.1365- 2222.1998.00399.x.
36. Bucher X, Pichler WJ, Dahinden CA, Helbling A. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 2004; 59:1272-6; PMID:15507095; http://dx.doi.org/10.1111/j. 1398-9995.2004.00626.x.
37. Kinaciyan T, Jahn-Schmid B, Radakovics A, Zwölfer B, Schreiber C, Francis JN, et al. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Betv1 homolog Mal d 1. J Allergy Clin Immunol 2007; 119:937-43; PMID:17204315; http:// dx.doi.org/10.1016/j.jaci.2006.11.010.
38. Mauro M, Russello M, Incorvaia C, Gazzola G, Frati F, Moingeon P, et al. Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol 2011; 156:416-22; PMID:21832831; http:// dx.doi.org/10.1159/000323909.
39. King N, Helm R, Stanley JS, Vieths S, Lüttkopf D, Hatahet L, et al. Allergenic characteristics of a modified peanut allergen. Mol Nutr Food Res 2005; 49:963- 71; PMID:16189800; http://dx.doi.org/10.1002/ mnfr.200500073.
40. Li XM, Srivastava K, Grishin A, Huang CK, Schofield B, Burks W, et al. Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 2003; 112:159- 67; PMID:12847493; http://dx.doi.org/10.1067/ mai.2003.1622.
41. Li S, Li XM, Burks AW, Bannon GA, Sampson HA. Modulation of peanut allergy by peptide-based immunotherapy. J Allergy Clin Immunol 2001; 107:S233.
42. Rupa P, Mine Y. Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy. Allergy 2012; 67:74-82; PMID:21950267; http:// dx.doi.org/10.1111/j.1398-9995. 2011.02724.x.
43. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5:387-91; PMID:10202926; http://dx.doi.org/10.1038/7385.
44. Srivastava KD, Kattan JD, Zou ZM, Li JH, Zhang L, Wallenstein S, et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 2005; 115:171-8; PMID:15637565; http:// dx.doi.org/10.1016/j.jaci.2004.10.003.
45. Ko J. Effect of Chinese Herbal Formulas on T cell Responses in Patients with Peanut Allergy or Asthma. J Allergy Clin Immunol 2005; http://dx.doi. org/10.1016/j.jaci.2004.12.155.
46. Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC, Wortel CH, et al.; Avon Longitudinal Study of Parents and Children Study Team. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348:986-93; PMID:12637608; http:// dx.doi.org/10.1056/NEJMoa022613.
47. Sampson HA, Leung DY, Burks AW, Lack G, Bahna SL, Jones SM, et al. A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol 2011; 127:1309-10; PMID:21397314; http://dx.doi.org/10.1016/j.jaci.2011.01.051.
48. Shreffler WG, Wanich N, Moloney M, Nowak- Wegrzyn A, Sampson HA. Association of allergenspecific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol 2009; 123:43-52; PMID:19130927; http://dx.doi. org/10.1016/j.jaci.2008.09.051.